Prostate Clinical Trials Search

Current State: NCT ID:
Return to Map
TitleStateStatusNCT ID
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesNew JerseyRecruitingNCT00079001
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesNew JerseyRecruitingNCT00079001
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate CancerNew JerseyRecruitingNCT00215345
A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate CancerNew JerseyRecruitingNCT00218205
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate CancerNew JerseyRecruitingNCT00309985
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesNew JerseyRecruitingNCT00377156
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerNew JerseyRecruitingNCT00430183
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation TherapyNew JerseyRecruitingNCT00450411
Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate CancerNew JerseyRecruitingNCT00450463
153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate CancerNew JerseyRecruitingNCT00450619
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate CancerNew JerseyRecruitingNCT00567580
Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate CancerNew JerseyRecruitingNCT00582842
ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Metastatic Bone Tumors for the Palliation of PainNew JerseyRecruitingNCT00656305
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesNew JerseyRecruitingNCT00698308
Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate CancerNew JerseyRecruitingNCT00726596
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local TherapyNew JerseyRecruitingNCT00776594
Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to ChemotherapyNew JerseyRecruitingNCT00813423
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesNew JerseyRecruitingNCT00874211
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After CastrationNew JerseyRecruitingNCT00878436
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation TherapyNew JerseyRecruitingNCT00925600
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerNew JerseyRecruitingNCT00936390
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerNew JerseyRecruitingNCT00942331
Phase 3 Study of Immunotherapy to Treat Advanced Prostate CancerNew JerseyRecruitingNCT01057810
Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate CancerNew JerseyRecruitingNCT01193257
Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate CancerNew JerseyRecruitingNCT01200810
Study of Abiraterone Acetate in Patients With Advanced Prostate CancerNew JerseyAvailableNCT01217697
Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate CancerNew JerseyRecruitingNCT01220973
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate CancerNew JerseyRecruitingNCT01234311
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active SurveillanceNew JerseyRecruitingNCT01238172
Bicalutamide With or Without MK2206 in Treating Patients With Previously Treated Prostate CancerNew JerseyRecruitingNCT01251861
Cediranib Maleate With or Without Dasatinib in Patients With Hormone-Resistant Prostate Cancer Resistant to Treatment With DocetaxelNew JerseyRecruitingNCT01260688
Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyNew JerseyRecruitingNCT01270880
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate CancerNew JerseyRecruitingNCT01288911
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.New JerseyRecruitingNCT01302054
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of FesoterodineNew JerseyRecruitingNCT01302067
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerNew JerseyRecruitingNCT01306890
Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate CancerNew JerseyRecruitingNCT01308567
Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate CancerNew JerseyRecruitingNCT01308580
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific AntigenNew JerseyRecruitingNCT01314118
Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast CancerNew JerseyRecruitingNCT01338831
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate CancerNew JerseyRecruitingNCT01360840
A Study to Assess Efficacy and Safety With VESIcare® to Improve Urinary Continence in Subjects After Robotic Assisted Radical ProstatectomyNew JerseyRecruitingNCT01371994
Trial of Modifications to Radical ProstatectomyNew JerseyRecruitingNCT01407263
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate CancerNew JerseyRecruitingNCT01415960
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors or Prostate or Kidney CancerNew JerseyRecruitingNCT01480154
PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder TumorsNew JerseyNot yet recruitingNCT01567462
Abiraterone Acetate With or Without Veliparib in Treating Patients With Metastatic Prostate CancerNew JerseyRecruitingNCT01576172
Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate CancerNew JerseyRecruitingNCT01620515
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate CancerNew JerseyRecruitingNCT00063882
Methylselenocysteine Effects on Circadian RhythmNew JerseyRecruitingNCT01611038